Filing Details
- Accession Number:
- 0001209191-18-050301
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-10 17:02:35
- Reporting Period:
- 2018-09-06
- Accepted Time:
- 2018-09-10 17:02:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339358 | E Fred Cohen | Tpg Biotech 345 California Street Suite 3300 San Francisco CA 94104 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-06 | 8,250 | $34.44 | 75,572 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-06 | 8,250 | $61.51 | 67,322 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2018-09-06 | 8,250 | $0.00 | 8,250 | $34.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-06-08 | 2022-06-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,068 | Indirect | By the Jane K Cohen Trust |
Footnotes
- Represents weighted average sale price. Actual sale prices ranged from $61.33 to $61.76.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Billionaire Hedge Funds
